AVELOX- moxifloxacin hydrochloride injection, solution 
AVELOX- moxifloxacin hydrochloride tablet, film coated ABD - İngilizce - NLM (National Library of Medicine)

avelox- moxifloxacin hydrochloride injection, solution avelox- moxifloxacin hydrochloride tablet, film coated

schering plough corporation - moxifloxacin hydrochloride (unii: c53598599t) (moxifloxacin - unii:u188xyd42p) - moxifloxacin 400 mg in 250 ml - avelox is indicated in adult patients for the treatment of community acquired pneumonia caused by susceptible isolates of streptococcus pneumoniae (including multi-drug resistant streptococcus pneumoniae [mdrsp]), haemophilus influenzae, moraxella catarrhalis, methicillin-susceptible staphylococcus aureus, klebsiella pneumoniae, mycoplasma pneumoniae, or chlamydophila pneumoniae [see clinical studies (14.3 )] . mdrsp isolates are isolates resistant to two or more of the following antibacterial drugs: penicillin (minimum inhibitory concentrations [mic] ≥ 2 mcg/ml), 2nd generation cephalosporins (for example, cefuroxime), macrolides, tetracyclines, and trimethoprim/sulfamethoxazole. avelox is indicated in adult patients for the treatment of uncomplicated skin and skin structure infections caused by susceptible isolates of methicillin-susceptible staphylococcus aureus or streptococcus pyogenes [see clinical studies (14.4 )]. avelox is indicated in adult patients for the treatment of complicated skin and ski

LAMOTRIGINE - lamotrigine tablet 
LAMOTRIGINE- lamotrigine tablet ABD - İngilizce - NLM (National Library of Medicine)

lamotrigine - lamotrigine tablet lamotrigine- lamotrigine tablet

mckesson corporation dba sky packaging - lamotrigine (unii: u3h27498ks) (lamotrigine - unii:u3h27498ks) - lamotrigine 100 mg - adjunctive therapy lamotrigine tablets are indicated as adjunctive therapy for the following seizure types in patients aged 2 years and older: - partial-onset seizures. - primary generalized tonic-clonic (pgtc) seizures. - generalized seizures of lennox-gastaut syndrome. monotherapy lamotrigine tablets are indicated for conversion to monotherapy in adults (aged 16 years and older) with partial-onset seizures who are receiving treatment with carbamazepine, phenytoin, phenobarbital, primidone, or valproate as the single antiepileptic drug (aed). safety and effectiveness of lamotrigine tablets have not been established (1) as initial monotherapy; (2) for conversion to monotherapy from aeds other than carbamazepine, phenytoin, phenobarbital, primidone, or valproate; or (3) for simultaneous conversion to monotherapy from 2 or more concomitant aeds. lamotrigine tablets are indicated for the maintenance treatment of bipolar i disorder to delay the time to occurrence of mood episodes (depression, mania, hypoman

TRAMADOL HYDROCHLORIDE- tramadol hydrochloride tablet, coated ABD - İngilizce - NLM (National Library of Medicine)

tramadol hydrochloride- tramadol hydrochloride tablet, coated

mckesson corporation dba sky packaging - tramadol hydrochloride (unii: 9n7r477wck) (tramadol - unii:39j1lgj30j) - tramadol hydrochloride 50 mg - tramadol hcl tablets are indicated for the management of pain in adults that is severe enough to require an opioid analgesic and for which alternative treatments are inadequate. limitations of use because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses (see warnings ), reserve tramadol hcl tablets for use in patients for whom alternative treatment options [e.g., non-opioid analgesics]: - have not been tolerated, or are not expected to be tolerated. - have not provided adequate analgesia, or are not expected to provide adequate analgesia. tramadol hcl tablets are contraindicated for: - all children younger than 12 years of age (see warnings ) all children younger than 12 years of age (see warnings ) - post-operative management in children younger than 18 years of age following tonsillectomy and/or adenoidectomy (see warnings ). post-operative management in children younger than 18 years of age following tonsillectomy and/or adenoidectomy (see warnings ). tramadol hcl t

LAMOTRIGINE tablet ABD - İngilizce - NLM (National Library of Medicine)

lamotrigine tablet

mckesson corporation dba sky packaging - lamotrigine (unii: u3h27498ks) (lamotrigine - unii:u3h27498ks) - lamotrigine 25 mg - adjunctive therapy: lamotrigine tablets are indicated as adjunctive therapy for the following seizure types in patients ≥2 years of age: - partial seizures - primary generalized tonic-clonic seizures - generalized seizures of lennox-gastaut syndrome  monotherapy: lamotrigine tablets are indicated for conversion to monotherapy in adults (≥16 years of age) with partial seizures who are receiving treatment with carbamazepine, phenytoin, phenobarbital, primidone, or valproate as the single antiepileptic drug (aed).  safety and effectiveness of lamotrigine tablets are have not been established (1) as initial monotherapy; (2) for conversion to monotherapy from aeds other than carbamazepine, phenytoin, phenobarbital, primidone, or valproate; or (3) for simultaneous conversion to monotherapy from 2 or more concomitant aeds. lamotrigine tablets are indicated for the maintenance treatment of bipolar i disorder to delay the time to occurrence of mood episodes (depression, mania, hypomania, mixed episodes) in adults (≥18

NITROGEN gas ABD - İngilizce - NLM (National Library of Medicine)

nitrogen gas

superior welding supply co - nitrogen (unii: n762921k75) (nitrogen - unii:n762921k75) - nitrogen 990 ml in 1 l

OXYGEN gas ABD - İngilizce - NLM (National Library of Medicine)

oxygen gas

superior welding supply co - oxygen (unii: s88tt14065) (oxygen - unii:s88tt14065) - oxygen 990 ml in 1 l

ALPRAZOLAM- alprazolam tablet ABD - İngilizce - NLM (National Library of Medicine)

alprazolam- alprazolam tablet

mckesson corporation dba sky packaging - alprazolam (unii: yu55mq3izy) (alprazolam - unii:yu55mq3izy) - alprazolam .25 mg - alprazolam tablets are indicated for the management of anxiety disorder (a condition corresponding most closely to the apa diagnostic and statistical manual [dsm-iii-r] diagnosis of generalized anxiety disorder) or the short-term relief of symptoms of anxiety. anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic. generalized anxiety disorder is characterized by unrealistic or excessive anxiety and worry (apprehensive expectation) about two or more life circumstances, for a period of 6 months or longer, during which the person has been bothered more days than not by these concerns. at least 6 of the following 18 symptoms are often present in these patients: motor tension (trembling, twitching, or feeling shaky; muscle tension, aches, or soreness; restlessness; easy fatigability); autonomic hyperactivity (shortness of breath or smothering sensations; palpitations or accelerated heart rate; sweating, or cold clammy hands; dry mouth; dizziness or l

ASPEN SUPERIOR 25 - iodine liquid ABD - İngilizce - NLM (National Library of Medicine)

aspen superior 25 - iodine liquid

exl laboratories, llc - iodine (unii: 9679tc07x4) (iodine - unii:9679tc07x4) - iodine 2500 mg in 1 l

ASPEN SUPERIOR BARRIER DIP - iodine liquid ABD - İngilizce - NLM (National Library of Medicine)

aspen superior barrier dip - iodine liquid

exl laboratories, llc - iodine (unii: 9679tc07x4) (iodine - unii:9679tc07x4) - iodine 10000 mg in 1 l

BUPROPION HYDROCHLORIDE- bupropion hydrochloride tablet, film coated ABD - İngilizce - NLM (National Library of Medicine)

bupropion hydrochloride- bupropion hydrochloride tablet, film coated

mckesson corporation dba sky packaging - bupropion hydrochloride (unii: zg7e5poy8o) (bupropion - unii:01zg3tpx31) - bupropion hydrochloride 75 mg - bupropion hydrochloride tablets are indicated for the treatment of major depressive disorder (mdd), as defined by the diagnostic and statistical manual (dsm) . the efficacy of bupropion hydrochloride tablets in the treatment of a major depressive episode was established in two 4-week controlled inpatient trials and one 6-week controlled outpatient trial of adult subjects with mdd [see clinical studies ( 14 )] . risk summary data from epidemiological studies of pregnant women exposed to bupropion in the first trimester indicate no increased risk of congenital malformations overall. all pregnancies, regardless of drug exposure, have a background rate of 2% to 4% for major malformations, and 15% to 20% for pregnancy loss. no clear evidence of teratogenic activity was found in reproductive developmental studies conducted in rats and rabbits; however, in rabbits, slightly increased incidences of fetal malformations and skeletal variations were observed at doses approximately equal to the maximum recommended human